Isabel Aranguez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Finerenone prevents renal damage by enhancing SDF-1α/CXCR4-mediated stem cell mobilization in experimental type 1 diabetic nephropathy.

Finerenone prevents renal damage by enhancing SDF-1α/CXCR4-mediated stem cell mobilization in experimental type 1 diabetic nephropathy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 03, 2025

Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats.

Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats.

Journal: International journal of molecular sciences

Published: October 20, 2023

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 07, 2023

Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease.

Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease.

Journal: International journal of molecular sciences

Published: October 04, 2022

Caloric restriction induces H2O2 formation as a trigger of AMPK-eNOS-NO pathway in obese rats: Role for CAMKII.

Caloric restriction induces H2O2 formation as a trigger of AMPK-eNOS-NO pathway in obese rats: Role for CAMKII.

Journal: Free radical biology & medicine

Published: April 11, 2019

Impact of pharmacist's intervention on reducing cardiovascular risk in obese patients.

Impact of pharmacist's intervention on reducing cardiovascular risk in obese patients.

Journal: International journal of clinical pharmacy

Published: September 25, 2018

Beneficial Effect of Bariatric Surgery on Abnormal MMP-9 and AMPK Activities: Potential Markers of Obesity-Related CV Risk.

Beneficial Effect of Bariatric Surgery on Abnormal MMP-9 and AMPK Activities: Potential Markers of Obesity-Related CV Risk.

Journal: Frontiers in physiology

Published: July 27, 2018

Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

Journal: British journal of pharmacology

Published: November 10, 2016

Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.

Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.

Journal: Clinical science (London, England : 1979)

Published: July 23, 2015

Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice.

Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice.

Journal: Vascular pharmacology

Published: January 16, 2015

Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats.

Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats.

Journal: Vascular pharmacology

Published: September 24, 2014

Vascular AMPK as an attractive target in the treatment of vascular complications of obesity.

Vascular AMPK as an attractive target in the treatment of vascular complications of obesity.

Journal: Vascular pharmacology

Published: September 01, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026